Abstract:Background: Continuous activation of the signal transducer and activator of transcription 3 (STAT3) signaling pathway contributes to cellular proliferation, angiogenesis and activation of anti-apoptosis pathways to promote tumor progression. Besides, STAT3 activation plays an important role in the polarisation of M2 macrophages and immune suppression. Our previous study found that glioma stem cells (SU3) could induce host macrophage malignance in the immune microenvironment, and a cancerous cell line SU3-induced host celiac tumor cells (SU3-ihCTCs) was obtained. We also found STAT3 was activated in SU3-ihCTCs. Methods: The ratio of F4/80 positive cells in SU3-ihCTCs was tested by flow cytometry, and the expression of p-STAT3 and macrophage markers were analyzed with RT-PCR or Western Blotting, respectively. SU3-ihCTCs were treated with 1–6 μmol/L WP1066 for 24 hours, then the expression of STAT3, p-STAT3, Bcl-2 and Cleaved caspase-3 were detected with Western Blotting, and the ratio of apoptosis were tested by flow cytometry. BalB/C nude mice received subcutaneous implants of SU3-ihCTCs, the tumor size was measured every other day, and the weight of tumor was measured. The expression of STAT3, p-STAT3, Bcl-2 and Cleaved caspase3 of the transplanted tumor were tested by Western Blotting and immunohistochemical analysis. Results: SU3-ihCTCs expressed higher of p-STAT3 and M2 macrophage makers. When SU3-ihCTCs were treated with the STAT3 inhibitor WP1066, the expressions of M2 makers, p-STAT3 and Bcl-2 of the cells were decreased, and the expression of cleaved caspase-3 was increased. At the same time, the proliferation of SU3-ihCTCs was inhibited and apoptosis was enhanced. In vivo studies had shown that WP1066 treatment significantly decreased the volume and weight of SU3-ihCTCs xenografts in nude mice, and immunohistochemical and Western blotting analyses showed that the expression levels of p-STAT3 and Bcl-2 decreased and those of the apoptosis-related protein caspase-3 were upregulated. Conclusions: We suggest that glioma stem cells induce host macrophage malignance in tumor microenvironment (TME), STAT3 pathway play an important role in the transformation process. These results present new evidence that macrophages in TME promote tumor proliferation. STAT3 signaling pathway may present a therapeutic target to suppress the tumor development.

IFITM3/STAT3 Axis Promotes Glioma Cells Invasion and is Modulated by TGF-β

IFITM3 promotes glioblastoma stem cell-mediated angiogenesis via regulating JAK/STAT3/bFGF signaling pathway

The Role of IFITM3 in the Growth and Migration of Human Glioma Cells

IFITM10 Enhance Tumor Angiogenesis and Promotes Cancer Progression through STAT3 Activation

Signal Transducer and Activator of Transcription 3 Promotes Angiogenesis and Drives Malignant Progression in Glioma

KIF3C Promotes Proliferation, Migration, and Invasion of Glioma Cells by Activating the PI3K/AKT Pathway and Inducing EMT

IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway

Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice

STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC

Interferon- inducible protein 30 promotes the epithelial-mesenchymal transition-like phenotype and chemoresistance by activating EGFR/AKT/GSK3/-catenin pathway in glioma

Il-6 Augments The Invasiveness Of U87mg Human Glioblastoma Multiforme Cells Via Up-Regulation Of Mmp-2 And Fascin-1

KIF3C is associated with favorable prognosis in glioma patients and may be regulated by PI3K/AKT/mTOR pathway

Effect of STAT3 signal pathway on the invasiveness of human glioma cell lines

Upregulation of microRNA‐133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway

Effect of signal transducer and activators of transcription 3 on migration of human glioblastoma cells

Glioma Stem-Like Cells Evade Interferon Suppression Through MBD3/NuRD Complex-Mediated STAT1 Downregulation

The role of STAT3 activation in modulating the immune microenvironment of GBM

FOXP3+ regulatory T cell perturbation mediated by the IFNγ-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity

STAT3 Signaling Pathway Regulates Glioma Stem Cells Induced Host Macrophage Malignance

Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells Via TGF-β1 Signaling Pathway

TRIB3 facilitates glioblastoma progression via restraining autophagy